By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Laboratory Corporation of America Holdings (LabCorp)  

1447 York Court

Burlington  North Carolina  27215  U.S.A.
Phone: 336-584-5171 or 800-331-2843 Fax: n/a



Celera Diagnostics  Collaboration agreement to establish the clinical utility of tests based on novel diagnostic markers for Alzheimer's disease, breast cancer and prostate cancer.

Company News
LabCorp (LH) And Cheeriodicals Spread Cheer To UNC Children’s 1/28/2016 10:26:57 AM
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp (LH) 1/12/2016 8:10:27 AM
Proprietary LabCorp (LH) Clinical Decision Support Report Improves Adherence To Chronic Kidney Disease Treatment Guidelines 1/5/2016 11:35:50 AM
Conversion Right Triggered For LabCorp (LH)’s Zero Coupon Convertible Subordinated Notes Due 2021 1/4/2016 7:40:55 AM
LabCorp (LH) Enters Into Definitive Agreement To Acquire Assets Of Pathology Inc. 12/10/2015 8:13:01 AM
LabCorp (LH) Launches New Enhanced Report For Medical Drug Monitoring 12/1/2015 12:27:17 PM
LabCorp (LH) Is Scheduled To Present At The 2015 Credit Suisse Healthcare Conference 11/3/2015 11:12:06 AM
LabCorp (LH) Announces 2015 Third Quarter Results 10/26/2015 12:36:06 PM
LabCorp (LH) Acquires Safe Foods International Holdings 10/23/2015 9:42:50 AM
LabCorp (LH) To Offer New PD-L1 Test For Bristol-Myers Squibb (BMY)’s OPDIVO Following Collaboration In Clinical Trial 10/12/2015 8:46:52 AM